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ABSTRACT 
During development, ribosome biogenesis and translation reach peak activities, due 
to impetuous cell proliferation. Current models predict that protein synthesis 
elevation is controlled by transcription factors and signalling pathways. 
Developmental models addressing translation factors overexpression effects are 
lacking. Eukaryotic Initiation Factor 6 (eIF6) is necessary for ribosome biogenesis 
and efficient translation. eIF6 is a single gene, conserved from yeasts to mammals, 
suggesting a tight regulation need. We generated a Drosophila melanogaster model 
of eIF6 upregulation, leading to a boost in general translation and the shut-down of 
the ecdysone biosynthetic pathway. Indeed, translation modulation in S2 cells 
showed that translational rate and ecdysone biosynthesis are inversely correlated. In 
vivo, eIF6-driven alterations delayed Programmed Cell Death (PCD), resulting in 
aberrant phenotypes, partially rescued by ecdysone administration. Our data show 
that eIF6 triggers a translation program with far-reaching effects on metabolism and 
development, stressing the driving and central role of translation. 
 
KEYWORDS 
eIF6, ecdysone, 20HE, translation, Drosophila development 
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INTRODUCTION 
During cell proliferation, ribosomal proteins (RPs) and eukaryotic Initiation Factors 
(eIFs) are necessary and in high demand for ribosome biogenesis and translation (1-
5). Proteins involved in ribosome biogenesis do not usually have a role in the 
translational control and vice versa (6). However, the eukaryotic Initiation Factor 6 
(eIF6) is remarkably unique (7): a nuclear pool is essential for nucleolar maturation 
of the 60S large subunit (8), while cytoplasmic eIF6 acts as a translation factor (8). 
Mechanistically, eIF6 is an anti-association factor: by binding 60S subunit, eIF6 
prevents its premature joining with a 40S not loaded with the pre-initiation complex. 
Release of eIF6 is then mandatory for the formation of an active 80S (9). The dual 
action of eIF6 in ribosome biogenesis and translation suggests that it may act as a 
master gene regulating ribosomal efficiency. Remarkably, point mutations of eIF6 
can revert the lethal phenotype of ribosome biogenesis factors such as SBDS (10) 
and eFL1p (11). eIF6 is highly conserved in yeast, fruit fly and humans (12). During 
evolution, the eIF6 gene has not been subjected to gene duplication. Despite its 
ubiquitous role, eIF6 levels are tightly regulated in vivo, showing considerable 
variability of expression among different tissues (13). Importantly, high levels of eIF6 
or hyperphosphorylated eIF6 are observed in some cancers (14, 15). eIF6 is rate 
limiting for tumor onset and progression in mice (16). In addition, eIF6 amplification 
is observed in luminal breast cancer patients (17) and affects cancer cell 
metastatization (18, 19). It has been recently demonstrated that eIF6 acts at the 
translational level through the regulation of metabolism: in mammals, eIF6 
translation activity increases fatty acid synthesis and glycolysis through the 
translation of transcription factors such as CEBP/β, ATF4 and CEBP/δ containing 
G/C rich or uORF sequences in their 5’UTR (20, 21). 
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However, whether eIF6 overexpression per se can change a transcriptional program 
in the absence of other genetic lesions is unknown. 
Ecdysone is the primary steroid hormone in insects: during fly development, it is 
produced as a precursor, ecdysone (E) in the prothoracic gland (PG). Biosynthesis 
starts from cholesterol and, after several enzymatic steps, it is secreted in the 
haemolymph. Target tissues convert ecdysone into the active form, the 20-
hydroxyecdysone (20HE) (22). The binding of 20HE with its receptor is responsible 
for a transcriptional cascade that triggers metamorphosis (23). Pulses of 20HE 
regulate several processes such as cell proliferation, differentiation and cell death 
(23-28). 
To determine the effects of eIF6 high levels in vivo, we took advantage of Drosophila 
melanogaster, an ideal model to manipulate gene expression in a time- and tissue-
dependent manner, using the GAL4/UAS system (29, 30). We reasoned that an 
overexpression approach could allow us to evaluate the effects of eIF6 increased 
activity in the context of an intact organism. To this end, we focused on the fly eye, 
an organ not essential for viability, whose development from epithelial primordia, the 
larval eye imaginal disc, is well known. The adult compound eye is a stunningly 
beautiful structure of approximately 800 identical units, called ommatidia (31). Each 
ommatidium is composed of eight neuronal photoreceptors, four glial-like cone cells 
and pigment cells (32, 33).  
By increasing eIF6 levels specifically in the eye, we found alterations in physiological 
apoptosis at the pupal stage, correlating with an increase in general translation.  
We observed that increased levels of eIF6 are responsible for a reshaping of the eye 
transcriptome that revealed a coordinated downregulation of the ecdysone 
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biosynthetic pathway during the larval stage. This study provides the first in vivo 
evidence that an increase in translation, dependent on heightened eIF6 levels, may 
drive metabolic changes and a transcriptional rewiring in a developing organ.  
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
6 
MATERIALS AND METHODS 
Genetics 
Fly strains were maintained on standard cornmeal food at 18°C. Genetic crosses 
were performed at 25°C, with the exception of GMRGAL4/+ and GMR>eIF6, 
performed at 18°C. The following fly mutant stocks have been used: GMRGAL4 was 
a gift from Manolis Fanto (King’s College, London); UAS-eIF6 was a gift from William 
J Brook (Alberta Children’s Hospital, Calgary). The eIF6 (GH08760) cDNA was 
obtained from the Berkeley Drosophila Genome project (Research Genetics) and 
sequenced for confirmation. The entire eIF6 cDNA was cloned into the RI site of the 
pUAST (34). Lines obtained from the Bloomington Drosophila Stock Center (BDSC): 
y[1] w[*]; P{w[+mC]=tubP-GAL4}LL7/TM3, Sb[1] Ser[1] (5138); spaGAL4 (26656) 
P{w[+mC]=spa-GAL4.J}1, w[*]; 54CGAL4 (27328) y[1] w[*]; P{w[+m*]=GAL4}54C; 
w1118 (3605) w[1118]; bxMS1096GAL4 (8860) w[1118] 
P{w[+mW.hs]=GawB}Bx[MS1096]. 
Mosaic analysis 
The eIF6k13214 mutant clones were created by Flippase (FLP) mediated mitotic 
recombination (35). The eIF6k13214 (P(w[+mC]=lacW) eIF6[k13214] ytr[k13214]) P 
element allele was recombined onto the right arm of chromosome two with the 
homologous recombination site (FRT) at 42D using standard selection techniques. 
Briefly, to create the FRT y+ pwn, eIF6k13214 chromosomes, eIF6k13214 was 
recombined onto the FRT chromosome originating from the y; P42D pwn[1] 
P{y+}44B/CyO parental stock. The yellow+ pwn eIF6k13214G418 resistant flies were 
selected to create stocks for clonal analysis. Similarly, stocks used for generating 
unmarked eIF6k13214 clones were created by recombining eIF6k13214 with the 42D 
FRT chromosome using the w[1118]; P42D P{Ubi-GFP}2R/CyO parental line. 
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Targeted mitotic wing clones were generated by crossing flies with UAS-FLP, the 
appropriate GAL4 driver and the suitable 42D FRT second chromosome with the 
42D FRT eIF6k13214. The hs induced eIF6k13214 mitotic clones were created by 
following standard techniques. Briefly, 24- and 48-hours larvae with the appropriate 
genotypes were heat shocked for 1 hour at 37°C foll owed by incubation at 25°C. 
S2 cell culture  
The Drosophila S2 cells (RRID: CVCL_TZ72) were grown in Schneider medium 
(Lonza, Basel, Switzerland, #04-351Q) supplemented with 10% Fetal Bovine Serum 
(FBS – #ECS0180L, Euroclone, Pero, Italy) and 5 mL of PSG 1X (100X composition: 
10000 U/mL Penicillin, 10 mg/mL Streptomycin and 200 mM L-Glutamine in citrate 
buffer, (#G1146, Sigma, St. Louis, MO, USA), and maintained as a semi-adherent 
monolayer at standard culture conditions at 25 °C w ithout CO2. For protein synthesis 
measurement, S2 cells were treated at 65-70% confluence with 1 µM rapamycin 
(#R8781, Sigma) for 2 hours or 1 µM insulin (#I0516, Sigma) for 12 hours, both at 25 
°C. For SUnSET assay, the medium was removed and re placed with fresh medium 
supplemented with 5 µg/mL puromycin (#A1113803, Thermofisher Scientific, 
Waltham, MA, USA) for 3 hours, and treated according to (36). 
RNA isolation and RNA sequencing 
Total RNA was extracted with the mirVanaTM isolation kit according to the 
manufacturer protocol (#AM 1560, ThermoFisher) from 10 eye imaginal discs (larval 
stage) or 10 retinae (pupal stage). The RNA quality was controlled with BioAnalyzer 
(Agilent, Santa Clara, CA, USA). Libraries for Illumina sequencing were constructed 
from 100 ng of total RNA with the Illumina TruSeq RNA Sample Preparation Kit v2 
(Set A) (Illumina, San Diego, CA, USA). The generated libraries were loaded on to 
the cBot (Illumina) for clustering on a HiSeq Flow Cell v3. The flow cell was then 
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sequenced using a HiScanSQ (Illumina). A paired-end (2×101) run was performed 
using the SBS Kit v3 (Illumina). Sequence deepness was at 35 million reads. For 
quantitative PCR, the same amount of RNA was retrotranscribed according to 
SuperScriptTM III First-Strand Synthesis SuperMix manufacturer protocol 
(#18080400, LifeTechnologies, Carlsbad, CA, USA). For RNA-Seq validation, 
TaqMan probes specific for eIF6 (Dm01844498_g1) and rpl32 (Dm02151827_g1) 
were used, together with standard primers (rpl32 Fwd 
CGGATCGATATGCTAAGCTGT, Rev CGACGCACTCYCYYGTCG; shd Fwd 
CGGGCTACTCGCTTAATGCAG, Rev AGCAGCACCACCTCCATTTC). Target 
mRNA quantification was performed by using ∆Ct-method with rpl32 RNA as an 
internal standard, performed on a StepOne Plus System (Applied Biosystems, Foster 
City, CA, USA).  
Bioinformatic Analysis  
Read pre-processing and mapping  
Three biological replicates were analyzed for GMRGAL4/+ and GMR>eIF6 larval eye 
imaginal discs and four biological replicates were analyzed for GMRGAL4/+ and 
GMR>eIF6 pupal retinae, for a total of 14 samples. Raw reads were checked for 
quality by FastQC software (version 0.11.2, S., A. FastQC: a quality control tool for 
high-throughput sequence data. 2010; Available from: 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc), and filtered to remove 
low quality calls by Trimmomatic (version 0.32) (37) using default parameters and 
specifying a minimum length of 50. Processed reads were then aligned to Drosophila 
melanogaster genome assembly GRCm38 (Ensembl version 79) with STAR 
software (version 2.4.1c) (38). 
Gene expression quantification and differential expression analysis.  
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HTSeq-count algorithm (version 0.6.1, option -s = no, gene annotation release 79 
from Ensembl) (39) was employed to produce gene counts for each sample. To 
estimate differential expression, the matrix of gene counts produced by HTSeq was 
analyzed by DESeq2 (version DESeq2_1.12.4) (40). The differential expression 
analysis by the DeSeq2 algorithm was performed on the entire dataset composed by 
both larvae and pupae samples. The two following comparisons were analyzed: 
GMR>eIF6 versus GMRGAL4/+ larval eye imaginal discs (6 samples overall) and 
GMR>eIF6 versus GMRGAL4/+ pupal retinae (8 samples in total). Reads counts 
were normalized by calculating a size factor, as implemented in DESeq2. 
Independent filtering procedure was then applied, setting the threshold to the 62 
percentile; 10886 genes were therefore tested for differential expression. 
Significantly modulated genes in GMR>eIF6 genotype were selected by considering 
a false discovery rate lower than 5%. Regularized logarithmic (rlog) transformed 
values were used for heat map representation of gene expression profiles. Analyses 
were performed in R version 3.3.1 (2016-06-21, Computing, T.R.F.f.S. R: A 
Language and Environment for Statistical Computing. Available from: http://www.R-
project.org/).  
Functional analysis by topGO 
The Gene Ontology enrichment analysis was performed using topGO R 
Bioconductor package (version topGO_2.24.0). The option nodesize = 5 is used to 
prune the GO hierarchy from the terms which have less than 5 annotated genes and 
the annFUN.db function is used to extract the gene-to-GO mappings from the 
genome-wide annotation library org.Dm.eg.db for D. melanogaster. The statistical 
enrichment of GO was tested using Fisher’s exact test.  Both the “classic” and “elim” 
algorithms were used.  
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Gene set association analysis 
Gene set association analysis for larvae and pupae samples was performed by 
GSAA software (version 2.0) (41). Raw reads for 10886 genes identified by Entrez 
Gene ID were analyzed by GSAASeqSP, using gene set C5 (Drosophila version 
retrieved from http://www.go2msig.org/cgi-bin/prebuilt.cgi?taxid=7227) and 
specifying as permutation type ‘gene set’ and as gene set size filtering min 15 and 
max 800.  
Western blotting and antibodies 
Larval imaginal discs, pupal retinae and adult heads were dissected in cold 
Phosphate Buffer Saline (Na2HPO4 10 mM, KH2PO4 1.8 mM, NaCl 137 mM, KCl 2.7 
mM, pH 7.4) (PBS) and then homogenized in lysis buffer (HEPES 20 mM, KCl 100 
mM, Glycerol 5%, EDTA pH 8.0 10 mM, Triton-X 0.1%, DTT 1mM) freshly 
supplemented with Protease Inhibitors (Sigma, St. Louis, MO, USA, #P8340). 
Protein concentration was determined by BCA analysis (Pierce, Rockford, IL, USA, 
#23227). Equal amounts of proteins were loaded and separated on a 10% SDS-
PAGE, then transferred to a PVDF membrane. Membranes were blocked in 10% 
Bovine Serum Albumin (BSA) in PBS-Tween (0.01%) for 30 minutes at 37°C. The 
following primary antibodies were used: rabbit anti-eIF6 (1:500, this study), rabbit 
anti-β-actin (1:4000, CST, Danvers, MA, USA, #4967; RRID: AB_330288), mouse 
anti-Puromycin (1:500, Merck Millipore, #MABE343; RRID: AB_2566826). To 
produce the anti-eIF6 antibody used in this study, a rabbit polyclonal antiserum 
against two epitopes on COOH-terminal peptide of eIF6 (NH2-CLSFVGMNTTATEI-
COOH eIF6 203-215 aa; NH2-CATVTTKLRAALIEDMS-COOH eIF6 230-245 aa) 
was prepared by PrimmBiotech (Milan, Italy, Ab code: 201212-00003 GHA/12), 
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purified in a CNBr-Sepharose column and tested for its specificity against a mix of 
synthetic peptides with ELISA test. The following secondary antibodies were used: 
donkey anti-mouse IgG HRP (1:5000, GE Healthcare, Little Chalfont, UK, Amersham 
#NA931; RRID: AB_772210) and donkey anti-rabbit IgG HRP (1:5000, GE 
Healthcare, Amersham #NA934; RRID: 772206). 
SUnSET Assay 
Larval imaginal eye and wing discs were dissected in complete Schneider medium 
(Lonza, Basel, Switzerland) and treated ex vivo with puromycin (50 µg/mL) for 30 
minutes at room temperature, then fixed in 3% paraformaldehyde (PFA) for 1 hour at 
room temperature. Immunofluorescences were then performed as described below, 
using a mouse anti-puromycin (1:500, Merck Millipore, Billerica, MA, USA, 
#MABE343, RRID: AB_2566826) as a primary antibody. Discs were then examined 
by confocal microscope (Leica SP5, Leica, Wetzlar, Germany) and fluorescence 
intensity was measured with ImageJ software.  
Cell count  
GMRGAL4/+ and GMR>eIF6 pupal retinae at 40h APF were dissected, fixed, and 
stained with anti-Armadillo to count cells, as previously described (42). Cells 
contained within a hexagonal array (an imaginary hexagon that connects the centres 
of the surrounding six ommatidia) were counted; for different genotypes, the number 
of cells per hexagon was calculated by counting cells, compared with the 
corresponding control. Cells at the boundaries between neighbouring ommatidia 
count half. At least 3 hexagons (equivalent to 9 full ommatidia) were counted for 
each genotype, and phenotypes were analyzed. Standard Deviation (SD) and 
unpaired two-tailed Student t-test were used as statistical analysis. 
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Immunofluorescences, antibodies and TUNEL Assay 
Larval imaginal discs and pupal retinae were dissected in cold PBS and fixed in 3% 
paraformaldehyde (PFA) for 1 hour at room temperature, then washed twice with 
PBS and blocked in PBTB (PBS, Triton 0.3%, 5% Normal Goat Serum and 2% 
Bovine Serum Albumin) for 3 hours at room temperature. Primary antibodies were 
diluted in PBTB solution and incubated O/N at 4°C. After three washes with PBS, 
tissues were incubated O/N at 4°C with secondary an tibodies and DAPI (1:1000, 
Molecular Probes, Eugene, OR, USA, #D3571) in PBS. After three washes with 
PBS, eye imaginal discs and retinae were mounted on slides with ProLong Gold 
(LifeTechnologies, Carlsbad, CA, USA, #P36930). The following primary antibodies 
were used: rabbit anti-eIF6 (1:50, this study), rat anti-ELAV (1:100, Developmental 
Study Hybridoma Bank DSHB, Iowa City, IA, USA, #7E8A10; RRID: AB_528218), 
mouse anti-CUT (1:100, DSHB, #2B10; RRID: AB_528186), mouse anti-Armadillo 
(1:100, DSHB, #N27A; RRID: AB_528089), mouse anti-Chaoptin (1:100, DSHB, 
#24B10; RRID: AB_528161), rabbit anti- Dcp-1 (1:50, CST, #9578; RRID: 
AB_2721060), mouse anti-Puromycin (1:500, Merck Millipore, #MABE343; RRID: 
AB_2566826). The following secondary antibodies were used: goat anti-rat, goat 
anti-mouse, goat anti-rabbit (1:500 Alexa Fluor® secondary antibodies, Molecular 
Probes; RRID: AB_142924; AB_143157; AB_141778). Dead cells were detected 
using the In Situ Cell Death Detection Kit TMR Red (Roche, Basel, Switzerland, 
#12156792910) as manufacturer protocol, with some optimizations. Briefly, retinae of 
the selected developmental stage were dissected in cold PBS and fixed with PFA 
3% for 1 hour at room temperature. After three washes in PBS, retinae were 
permeabilized with Sodium Citrate 0.1%-Triton-X 0.1% for 2 minutes at 4°C and then 
incubated overnight at 37°C with the enzyme mix. Re tinae were then rinsed three 
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times with PBS, incubated with DAPI to stain nuclei and mounted on slides. Discs 
and retinae were examined by confocal microscopy (Leica SP5) and analyzed with 
Volocity 6.3 software (Perkin Elmer, Waltham, MA, USA).  
Semithin sections 
Semithin sections were prepared as described in (43). Adult eyes were fixed in 0.1 M 
Sodium Phosphate Buffer, 2% glutaraldehyde, on ice for 30 min, then incubated with 
2% OsO4 in 0.1 M Sodium Phosphate Buffer for 2 hours on ice, dehydrated in 
ethanol (30%, 50%, 70%, 90%, and 100%) and twice in propylene oxide. Dehydrated 
eyes were then incubated O/N in 1:1 mix of propylene oxide and epoxy resin (Sigma, 
Durcupan™ ACM). Finally, eyes were embedded in pure epoxy resin and baked O/N 
at 70°C. The embedded eyes were cut on a Leica Ultr aCut UC6 microtome using a 
glass knife and images were acquired with a 100X oil lens, Nikon Upright XP61 
microscope (Nikon, Tokyo, Japan).  
Ecdysone treatment 
For ecdysone treatment, 20-HydroxyEcdysone (20HE) (Sigma, #H5142) was 
dissolved in 100% ethanol to a final concentration of 5 mg/mL; third instar larvae 
from different genotypes (GMRGAL4/+ and GMR>eIF6) were collected and placed in 
individual vials on fresh standard cornmeal food supplemented with 240 µg/mL 
20HE. Eye phenotype was analyzed in adult flies, and images were captured with a 
TOUPCAM™ Digital camera. Eye images were analyzed with ImageJ software. 
In vitro Ribosome Interaction Assay (iRIA) 
iRIA assay was performed as described in (44). Briefly, 96-well plates were coated 
with a cellular extract diluted in 50 µL of PBS, 0.01% Tween-20, O/N at 4°C in a 
humid chamber. The coating solution was removed and unspecific sites were 
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blocked with 10% BSA, dissolved in PBS, 0.01% Tween-20 for 30 minutes at 37 °C. 
Plates were washed with 100 µL/well with PBS-Tween. 0.5 µg of recombinant 
biotinylated eIF6 were resuspended in a reaction mix: 2.5 mM MgCl2, 2% DMSO and 
PBS-0.01% Tween, to reach 50 µL of final volume/well, added to the well and 
incubated with coated ribosomes for 1 hour at room temperature. To remove 
unbound proteins, each well was washed 3 times with PBS, 0.01% Tween-20. HRP-
conjugated streptavidin was diluted 1:7000 in PBS, 0.01% Tween-20 and incubated 
in the well, 30 minutes at room temperature, in a final volume of 50 µL. Excess of 
streptavidin was removed through three washes with PBS-Tween. OPD (o-
phenylenediamine dihydrochloride) was used according to the manufacturer’s 
protocol (Sigma-Aldrich) as a soluble substrate for the detection of streptavidin-
peroxidase activity. The signal was detected after the incubation, plates were read at 
450 nm on a multiwell plate reader (Microplate model 680, Bio-Rad, Hercules, CA, 
USA).  
EIA assay 
Ecdysone levels from eye imaginal discs and retinae were titred according to the 
20HE Enzyme Immunoassay kit  protocol (Bertin Pharma, Montigny le Bretonneux, 
France, #A05120.96). Standard curves were generated using 20HE provided by the 
kit. Absorbance was measured at 405 nm with Tecan Freedom EVO (Tecan, 
Männedorf, Switzerland). 
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RESULTS 
Increased eIF6 levels cause embryonic lethality and aberrant morphology  
Regulation of eIF6 levels is stringent in normal conditions (13), with evidence for 
eIF6 amplification (17) and overexpression (12, 14, 45-47) in cancer. We used the 
Drosophila melanogaster model to establish whether an increased activity of eIF6 
could drive specific developmental decisions. 
First, we assessed the effects caused by the loss of the eIF6 D. melanogaster 
homologue. To this end, we used the P element allele eIF6k13214 (48), to induce 
mitotic clones homozygous for eIF6k13214 in first instar larvae by heat shock-induced 
FLIP/FLP-mediated homologous recombination (35). We did not observe clones of 
eIF6 mutant cells in all adult tissues, with the exception of small ones in the wing 
margin (S1A Fig). Similar results were obtained in a minute background that 
provides a growth advantage to mutant cells, or by targeted expression of FLP in the 
wing margin (S1A Fig). Together, these results confirm that eIF6 is required for cell 
viability in Drosophila, as previously observed in yeast (15) and mammals (8), 
precluding significant studies on the effects of eIF6 inhibition. 
Next, we assessed the effects of eIF6 high levels, by ubiquitous expression of eIF6 
under the TubGAL4 driver. Ectopic expression resulted in late embryonic lethality 
(S1B Fig). To circumvent early lethality, we focused on a non-essential fly organ, the 
eye. Increased eIF6 expression during late larval eye disc development, driven by 
the GMRGAL4 driver (GMR>eIF6), causes the formation of a reduced and rough 
adult eye (Fig 1A). We developed a new antibody specific for Drosophila eIF6 and 
we estimated its protein levels (Materials and Methods section) was about doubled 
compared to control (Fig 1B). The stereotypic structure of the wild-type eye was 
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severely disrupted with flattened ommatidia and bristles arranged in random patterns 
as shown by SEM analysis (Fig 1C). Semithin sections evidenced an aberrant 
morphology and arrangement of ommatidia (Fig 1D). These data show that 
increasing eIF6 levels in the fly eye cause a disruption of eye development. 
 
Increased eIF6 levels delay physiological apoptosis  
To understand the origin of the defects observed in GMR>eIF6 adult eyes, we 
analyzed eye development in larvae, starting from the third instar, the stage at which 
the GMR driver starts to be expressed. We found that third instar imaginal discs with 
high levels of eIF6 showed no differences in terms of morphology, cell identity or 
developmental delay when compared to control (S2A-B Fig). Then, we analyzed 
pupal development. In GMR>eIF6 retinae at 40h after puparium formation (APF) 
both neuronal and cone cells were present in the correct numbers. However, 
ommatidial morphology was altered (S2C Fig). A fundamental event controlling 
ommatidial morphology is the developmentally-controlled wave of Programmed Cell 
Death (PCD), sweeping the tissue from 25h to 42h APF (33). Thus, we analyzed by 
immunostaining the expression of Drosophila apoptotic effector caspase Dcp-1, as a 
marker of PCD, at 40h APF. Control retinae showed a clear presence of apoptotic 
cells. Remarkably, apoptotic cells were reduced in GMR>eIF6 retinae (Fig 2A).  
Dcp-1 positive cells, i.e. apoptotic cells, increased in GMR>eIF6 retinae at 60h APF 
(Fig 2B). In summary, quantification of the number of Dcp-1 positive cells at 40h APF 
and 60h APF in GMR>eIF6 revealed up to 75% reduction in the number of apoptotic 
cells at 40h APF, and an increase at 60h APF retinae (Fig 2C-D). A change in 
apoptosis dynamics was also visualized by TUNEL assay at 28h APF, the time at 
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which PCD starts in control retinae. Here, we observed the reduction of apoptotic 
nuclei in the GMR>eIF6 retinae, while GMRGAL4/+ retinae showed several (S2D 
Fig). In conclusion, eIF6 overexpression either blocks the early apoptotic program or 
delays it. We stained for the Drosophila β-catenin homologue Armadillo (Fig 3), 
which localizes to membranes of cells surrounding photoreceptors, providing an 
indication of ommatidial cell number. At 40h APF, control retinae presented the 
typical Armadillo staining. GMR>eIF6 retinae showed the presence of extra-
numerary cells around the ommatidial core (Fig 3A), indicating that interommatidial 
cells (IOCs) were not removed by PCD. By counting the number of cells in each 
ommatidium, we determined that GMR>eIF6 retinae possess more than 13 cells, 
corresponding to approximately 30% more than that of a wild-type ommatidium (S3A 
Fig). Later in development, at 60h and at 72h APF, in GMR>eIF6 retinae Armadillo 
was no longer detectable, while in wild-type retinae the pattern of Armadillo was 
maintained (Fig 3B and S3B Fig). These data indicate that delayed PCD in 
GMR>eIF6 inappropriately removes most IOCs. We suggest that the first effect of 
eIF6 high levels is an early block of apoptosis that leads in turn to an aberrant 
developmental program. 
 
Increased eIF6 expression in cone cells is sufficient to delay apoptosis 
Cone cells and IOCs are known to be the main actors during physiological PCD (49). 
We overexpressed eIF6 under the control of the cone cell-specific driver, spaGAL4. 
We observed a milder phenotype compared to GMR>eIF6 adult eyes (Fig 4A-B and 
S4A Fig). Importantly, eIF6 overexpression in cone cells (S4B Fig) caused reduced 
Dcp-1 staining in 40h APF retinae (Fig 4C), and evident apoptosis at 60h APF (Fig 
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4D), in line with what we observed in GMR>eIF6 retinae. Thus, the expression of 
eIF6 in cone cells is sufficient to alter PCD and cause defects in eye development. 
 
eIF6 expression reshapes the transcriptome, increases ribosome activity and 
represses ecdysone signalling 
Next, we asked whether eIF6 was associated with a transcriptional rewiring that 
could account for the observed phenotypic effects. To this end, we performed a 
comprehensive gene expression analysis of GMRGAL4/+ and GMR>eIF6 genotypes 
at two distinct stages of eye development, larval eye imaginal discs and pupal 
retinae, by RNA-Seq (Fig 5). In GMR>eIF6 samples at both developmental stages, 
we observed an upregulation of genes involved in ribosome biogenesis (Fig 5A, S1 
File). GSAA analysis revealed also an increase in mRNAs of genes involved in rRNA 
processing (Fig 5C). Overall these data suggest that eIF6 is able to increase 
ribosomal gene expression. 
Consistent with our phenotypic analysis of the eye, GMR>eIF6 retinae displayed 
also variations in genes involved in eye development and in PCD (Fig 5A, D and S1 
File). Notably, mRNAs encoding specialized eye enzymes, such as those of pigment 
biosynthetic pathways, were downregulated in GMR>eIF6 samples (S1 File), 
preceding the altered adult eye morphology.  
Finally, coordinated changes induced by eIF6 in eye imaginal discs surprisingly 
clustered into the ecdysone pathway, with a striking downregulation of many 
enzymes involved in 20-HydroxyEcdysone (20HE) biosynthesis (Fig 5 A-B). For 
instance, expression of phm, sad and nvd (S5 Fig) was virtually absent in GMR>eIF6 
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eye imaginal disc, while early (rbp) and late (ptp52f) responsive genes belonging to 
the hormone signalling cascade were downregulated (S1 File). In conclusion, our 
gene expression analysis of GMR>eIF6 eye samples identifies a rewiring of 
transcription that is consistent with altered PCD, accompanied by upregulation of 
ribosomal genes and downregulation of the ecdysone biosynthetic pathway. 
 
Increased eIF6 levels result in elevated translation 
eIF6 binds free 60S in vitro and in vivo affecting translation (7). To assess whether 
increased transcription of genes related to ribosome biogenesis and rRNA 
processing observed in gene expression analysis experiments was accompanied by 
an effect on the translational machinery, we investigated changes in levels of free 
60S subunits upon eIF6 overexpression. To this end, we performed the in vitro 
Ribosome Interaction Assay (iRIA) (44), able to measure quantitative binding of 
proteins to ribosomes. We found that the expression of eIF6 in GMR>eIF6 larval eye 
discs led to a 25% reduction in free 60S sites when compared to control (Fig 6A). 
Next, we used a modified SUnSET assay (36), as a proxy of the translational rate. 
We measured translation in eye imaginal discs treated ex vivo with puromycin, which 
incorporates in nascent protein chains by ribosomes. Remarkably, GMR>eIF6 eye 
discs incorporated almost twice the amount of puromycin, relative to control (Fig 6B-
C). Taken together, high levels of eIF6 increase the free 60S pool in vivo, and 
increase puromycin incorporation, i.e. translation.  
We next determined whether the increase of translation, altered morphology and 
apoptosis correlate with heightened eIF6 levels in other organs. Thus, we 
overexpressed eIF6 in the wing imaginal disc, using the bxMS1096GAL4 driver 
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(MS>eIF6) (S6A Fig). Such manipulation led to complete disruption of the adult wing 
structure (Fig 6D). Moreover, we performed the SUnSET assay on wing imaginal 
discs, and, as in eye discs, we observed a two-fold increase in puromycin 
incorporation in MS>eIF6 wing discs’ respect to control (Fig 6E and S6B Fig). 
Finally, eIF6 overexpression in wing discs led to an increase of apoptotic cells in the 
dorsal portion of the disc (S6C Fig), as observed in 60h APF GMR>eIF6 retinae. In 
conclusion, high levels of eIF6 lead not only to augmented expression of ribosomal 
genes, but also to augmented translational activity. 
 
20HE administration rescues adult eye defects induced by increased eIF6 
levels 
Transcriptome analysis revealed a coordinated shut-down of the 20HE biosynthetic 
pathway raising the question whether 20HE administration could at least partly 
rescue the defects driven by eIF6 increased levels, and a rough eye phenotype 
characterized by aberrant PCD. To determine the hierarchy of events that eIF6 
overexpression causes, we administrated 20HE by feeding GMR>eIF6 third instar 
larvae and we evaluated the effect on eye development. Remarkably, GMR>eIF6 
larvae fed with 20HE showed eyes that were 20% larger than untreated controls (Fig 
7A-B). We also assessed the levels of apoptosis at 40h APF. Notably, 
immunofluorescence staining for Dcp-1 showed the presence of apoptotic cells in 
40h APF GMR>eIF6 retinae treated with 20HE, while GMR>eIF6 untreated retinae 
did not show any Dcp-1 positive cells (Fig 7C). Taken together, these data suggest 
that the apoptotic defect and eye roughness caused by eIF6 overexpression are at 
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least partly due to the inactivation of ecdysone signalling, that precedes deregulation 
of PCD. 
 
eIF6 and translation antagonize ecdysone biosynthesis during development  
Our findings indicate that increased eIF6 levels cause downregulation of mRNAs 
belonging to the ecdysone biosynthetic pathway, and the relative absence of its final 
product, the 20HE. To understand the physiological relevance of this phenomenon, 
we measured mRNAs levels of eIF6 and shd at different stages of development (Fig 
7). Shd encodes for the last enzyme of the 20HE biosynthesis and it is specifically 
expressed in ecdysone target tissues (50). Real-Time PCR evidenced the 
downregulation of shd in eye imaginal disc overexpressing eIF6 (Fig 7D). We then 
investigated the levels of eIF6 and shd during development in wild-type tissues (Fig 
7E-F). Interestingly, we found that eIF6 levels are regulated during development, and 
that shd levels drop when eIF6 levels are high, both in embryos and first instar larvae 
(Fig 7E) or first and third instar larvae (Fig 7F). Importantly, 20HE levels drop at 40h 
APF retinae upon eIF6 overexpression (Fig 7G). Taken together, data suggest that 
physiological eIF6 levels are inversely correlated with 20HE production.  
Taken that high levels of eIF6 lead to an increase in general translation, we decided 
to study the relationship between the translational rate and ecdysone production in a 
physiological context. We assessed levels of shd and EcR (as an index of the feed-
forward loop induced by 20HE itself (51)) mRNA levels in S2 cells after treatment 
with rapamycin or insulin to inhibit or stimulate translation respectively (Fig 7H-J). 
After insulin treatment, we observed the downregulation of shd and EcR mRNA 
levels (Fig 7H). Conversely, after rapamycin treatment, we found an upregulation of 
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the two analyzed genes (Fig 7J). These data support a physiological model in which 
translation is a negative regulator of ecdysone metabolism. 
 
DISCUSSION 
Eukaryotic Initiation Factor 6 eIF6 is an evolutionarily conserved gene encoding for a 
protein necessary for ribosome biogenesis and translation initiation (8, 9). However, 
in mammals, eIF6 expression differs among tissues, with high levels in embryos and 
in cycling cells and almost undetectable levels in post-mitotic cells (13). 
Developmental studies in mice demonstrated that null alleles for this initiation factor 
are incompatible with life (8), whereas eIF6 haploinsufficiency is linked to an 
impairment in G1/S cell cycle progression (8). In unicellular models, eIF6 mutations 
rescue the quasi-lethal phenotype due to loss of ribosome biogenesis factors such 
as SBDS (10). Taken together, these data highlight how eIF6 expression, despite its 
ubiquitous function, is strictly regulated. Indeed, we found that doubling levels of 
eIF6 during development disrupts eye morphology, increases translation and 
changes gene expression. Overall, our data demonstrate that eIF6 is a translation 
factor able to drive a complex transcriptional reshaping.  
Mechanistically, eIF6 binds to the 60S in the intersubunit space, interacting with 
rpL23 and to the sarcin-loop (SRL) of rpL24 (52), thus generating a steric hindrance 
that prevents the formation of an intersubunit bridge (53). In vitro, eIF6 can repress 
translation (54). In mice, however, high levels of eIF6 are required for both tumor 
progression (16), and insulin-controlled translation (7, 8). In Drosophila, we found 
that the overexpression of eIF6 leads to a reduction of the free 60S pool in eye 
imaginal discs, consistent with eIF6 biochemical activity. Such reduction could imply 
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lower general translation, due to less availability of 60S subunits, as in the case of 
Sbds mutants (55). Conversely, 60S could be already engaged with 40S into active 
translating 80S, thus heightening general translation. We favour the latter hypothesis 
because, by a puromycin incorporation assay, we observe a two-fold increase in 
general translation, both in the developing eye and the wing. Intriguingly, the 
transcriptome signature associated with high levels of eIF6 revealed also an 
increase in mRNAs encoding for rRNA processing factors, suggesting that ribosome 
biogenesis is positively affected by eIF6. In conclusion, we surmise that in vivo eIF6 
may act as a powerful stimulator of ribosome synthesis and translation.  
The effects associated with increased translation driven by eIF6 are at least two, a 
change in the ecdysone pathway and a delay in apoptosis. We found a strong 
reduction of ecdysone biosynthesis pathway in the eye imaginal disc driven by eIF6. 
Importantly, 40h APF retinae evidence a reduction in hormone levels and 20HE 
administration leads to a partial rescue of the developmental defects driven by eIF6 
increased activity. Thus, our data suggest that eIF6 is upstream of ecdysone 
regulation. It has been recently suggested how translation regulation and hormonal 
signalling are tightly interconnected in Drosophila (56) and, more generally, that 
translation is a controller of metabolism (57, 58). Our experiments unveil an inverse 
correlation between translational capability and ecdysone production. Concerning 
apoptosis we showed that eIF6 expression leads to an early block in Programmed 
Cell Death, as previously demonstrated by others in X. laevis (59). The 
developmental defects driven by increased eIF6 levels are consistent with two 
scenarios: excess eIF6 could delay developmental PCD. Alternatively, PCD could be 
repressed at the correct developmental time and apoptotic elimination of defective 
cells overexpressing eIF6 could be triggered later independently of developmental 
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signals. The fact that overexpression of eIF6 in wing discs, which are not subjected 
to a developmental wave of apoptosis, leads to cell death, supports the latter 
hypothesis. 
The developmental changes due to eIF6-driven translation are dramatic and include 
lethality, as well as disruption of development. In the past, similar effects were 
observed by the expression of another rate-limiting factor in translational initiation, 
eIF4E (60). It is unknown whether the developmental defects driven by eIF4E 
overexpression also included the arrest of ecdysone biosynthetic pathway, or an 
apoptotic block. However, in mammalian models, eIF4E and eIF6 share the common 
property of being rate-limiting for tumor growth and translation in several contexts 
(61-67). 
The signalling to eIF6 is different from signalling to eIF4E (68), but the effects of 
inhibition of eIF4F complex by rapamycin are similar to eIF6 inhibition (8, 69). This 
result may reflect the fact that both eIF6 and eIF4F converge on similar metabolic 
pathways like lipid synthesis (20, 57) In summary, our study demonstrates that 
overexpression of eIF6 in developing organs is sufficient to induce an increase in 
ribosome biogenesis and translation that correlates with complex transcriptional and 
metabolic changes leading to hormonal and apoptotic defects. It will be interesting to 
further dissect the relationship between epigenetic, metabolic, and transcriptional 
changes associated with heightened eIF6 levels. Furthermore, our model may also 
be useful for in vivo screenings of compounds that suppress the effect of eIF6 
overexpression.  
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Supporting Information captions: 
S1. Strongly reduced or ubiquitously increased eIF6 levels are incompatible 
with life (A) eIF6k13214 mosaic analysis in wild type (Oregon R) wing margin and 
eIF6 mutant clones (i and ii). Wild type control anterior wing margin (iii and iv). Wing 
margin clones induced in Minute/eIF6k13214 flies (v and vi) according to the crosses 
outlined in Materials and Methods. Mutant clones induced along the wing margin by 
using UAS-Flp; C96-GAL4; FRTeIF6k13214/FRT y+ pwn flies (iv and vi). Arrows and 
arrowheads indicate pwn eIF6k13214 homozygous mutant and heterozygous Minute 
(M/pwn eIF6k13214) tissues, respectively. Asterisks denote y twin cells and the “^” 
highlights heterozygous wild type bristles. (B) Ectopic embryonic eIF6 phenotypes. 
Embryonic cuticle preparations in TubGAL4/+ and Tub>eIF6 evidencing that eIF6 
increased levels is embryonic lethal.  
S2. GMR>eIF6 eye imaginal discs retain cell identity and morphology, opposite 
to GMR>eIF6 retinae, which display altered morphology and PCD (A) 
GMR>eIF6 and GMRGAL4/+ eye imaginal discs stained for ELAV (neuronal cells 
marker) and Cut (cone cells marker) show that both neurons and cone cells preserve 
their identities upon eIF6 overexpression. (B) Counting ommatidial cluster rows in 
GMR>eIF6 and GMRGAL4/+ eye imaginal discs stained for ELAV shows that no 
developmental delay is associated with eIF6 overexpression. (A-B) Scale bar 50 µm. 
(C) Staining for ELAV, CUT and Chaoptin (intra-photoreceptor membranes marker) 
showing that both neurons and cone cells retain their identity. Noteworthy, neural 
and cone cells show an incorrect arrangement on the plane in association with 
increased eIF6 levels. Scale bar 10 µm. (D) TUNEL assay on early (28h APF) pupal 
stage retinae indicates that PCD is blocked at this developmental stage upon eIF6 
overexpression. Scale bar 50 µm. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
31 
S3. Cell number is altered in GMR>eIF6 retinae. (A) Comparison of cells number 
across two genotypes, GMRGAL4/+ and GMR>eIF6, shows that there is an increase 
in GMR>eIF6 with respect to control. ‘∆ cells per ommatidium’ refers to the number 
of cells gained or lost within an ommatidium (the number of cells in hexagon divided 
by 3). Results in the third column represent the mean ± SD, n=10. P-values were 
calculated using an unpaired two-tailed Student t-test. (B) Late-pupal stage (72h 
APF) retinae stained for Armadillo, the Drosophila β-catenin homologue, showing 
that when eIF6 is overexpressed cells around ommatidia are lost. Scale bar 10 µm. 
S4. Increasing eIF6 levels only in cone cells results in aberrant morphology (A-
B) Mid-pupal stage (40h APF) retinae of spaGAL4/+ and spa>eIF6 genotypes 
stained for ELAV and CUT confirm that neural and cone cell identity is retained, 
whereas cell arrangement is altered (A) upon eIF6 overexpression. (B) Mid-pupal 
stage (40h APF) retinae stained for eIF6 confirming that overexpression of eIF6 is 
restricted only to cone cells. (A-B) Scale bar 10 µm. 
S5. RNASeq analysis reveals a strong downregulation of genes related to 20-
HydroxyEcdysone biosynthesis. 20-HydroxyEcdysone biosynthetic pathway 
scheme. Genes involved in 20HE biosynthesis are strongly downregulated in 
GMR>eIF6 eye imaginal disc, with respect to control. p-values from RNASeq 
analysis. 
S6. eIF6 overexpression affects the wing. (A) Western Blot showing the levels of 
eIF6 expression in MSGAL4/+ and MS>eIF6 wing imaginal discs. Representative 
western blots from three independent experiments are shown to the left of each 
panel. (B) SUnSET assay performed using immunofluorescence experiment, 
indicating again a two-fold increase in general translation in MS>eIF6 wing discs. For 
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each genotype, two magnifications are compared: 40x (scale bar, 63 µm) and, in the 
small squares, 252x (scale bar, 10 µm). (C) Apoptosis is increased in MS>eIF6 wing 
imaginal disc. Wing discs stained for Dcp-1 and eIF6 in control flies (MSGAL4/+) and 
in MS>eIF6. In MS>eIF6 there is a striking increase in apoptotic events, compared to 
the control. Scale bar 35 µm. 
 
S1 File. Complete read counts of GMR>eIF6 and GMRGAL4/+ eye imaginal 
discs and pupal retinae List of all genes detected and tested for differential 
expression analysis in GMR>eIF6 and GMRGAL4/+ eye imaginal discs and pupal 
retinae. Gene quantification is calculated as normalized read counts. 
 
FIGURE CAPTIONS 
Fig 1. Increased eIF6 levels in the developing eye result in a rough eye 
phenotype (A) Representative stereomicroscope images of GMRGAL4/+ and 
GMR>eIF6 eyes, showing a rough eye phenotype. Scale bar 300 µm. (B) Western 
blot showing the levels of eIF6 expression in GMRGAL4/+ and GMR>eIF6 adult 
eyes. Representative western blots from three independent experiments are shown. 
Molecular weight markers (kDa) are shown to the left of each panel. The ratio was 
calculated with ImageJ software. The value corresponds to the intensity ratio 
between eIF6 and β-actin bands for each genotype. (C) Representative SEM images 
of GMRGAL4/+ and GMR>eIF6 adult eyes. eIF6 overexpressing eyes have an 
aberrant morphology, showing flattened ommatidia and randomly arranged bristles. 
Scale bar, respectively for 2400X, 5000X and 10000X magnifications are 10 µm, 5 
µm and 2.5 µm (D) Representative tangential sections of GMRGAL4/+ and 
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GMR>eIF6 adult eyes indicating that photoreceptors are still present in GMR>eIF6 
eyes, even if their arrangement is lost. Scale bar 10 µm.  
 
Fig 2. The apoptotic wave is delayed when eIF6 levels are increased. (A) Mid-
pupal stage retinae (40h APF) stained for the Drosophila caspase Dcp-1. 
GMRGAL4/+ retinae show Dcp-1 positive cells, indicating that PCD is ongoing at this 
developmental stage. On the contrary, GMR>eIF6 retinae do not show Dcp-1 
positive cells, indicating a block in PCD. Scale bar 10 µm. (B) Late-pupal stage (60h 
APF) retinae stained for the Drosophila caspase Dcp-1. GMRGAL4/+ retinae show a 
reduction of Dcp-1 positive cells, as expected (PCD already finished at this 
developmental stage). On the contrary, GMR>eIF6 retinae, show Dcp-1 positive 
cells, indicating a delay in PCD associated with more eIF6 levels. Scale bar 10 µm. 
(C-D) Barplot showing the Dcp-1 positive cells counts average from four different 
areas (n=4) at 40h APF (C) and 60h APF (D) retinae with error bars indicating the 
SEM. P-values were calculated using an unpaired two-tailed Student t-test. Dcp-1 
positive cells count indicates an overall delay and increases in PCD when eIF6 is 
increased during eye development.  
Fig 3. Cell number is altered during the pupal stage in GMR>eIF6 retinae. (A) 
Mid-pupal stage (40h APF) retinae stained for Armadillo, the Drosophila β-catenin 
homologue, showing that when eIF6 is increased there are extra-numerary cells 
(indicated as *) around each ommatidium. (B) Late-pupal stage (60h APF) retinae 
stained for Armadillo, showing the loss of all cells around ommatidia upon eIF6 
overexpression. (A-B) Scale bar 10 µm. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
34 
Fig 4. A specific increase of eIF6 in cone cells results in a rough eye 
phenotype. (A-B) Overexpression of eIF6 in cone cells results in rough eye 
phenotype. (A) Representative stereomicroscope images of spaGAL4/+ and 
spa>eIF6 eyes showing a rough eye phenotype. Scale bar 300 µm (B) 
Representative tangential semithin sections of spaGAL4/+ and spa>eIF6 adult eyes 
showing disruption of the structure upon eIF6 overexpression in cone cells. Scale 
bar 10 µm. (C) Mid-pupal stage (40h APF) retinae of spaGAL4/+ and spa>eIF6 
genotypes stained for Dcp-1 confirm the block in apoptosis already demonstrated in 
GMR>eIF6 retinae. (D) Late-pupal stage (60h APF) retinae of spaGAL4/+ and 
spa>eIF6 genotypes stained for Dcp-1 confirming the delayed and increased 
apoptosis already observed in GMR>eIF6 retinae. (C-D) Scale bar 10 µm.  
 
Fig 5. eIF6 induces a reshaping of transcription, resulting in rRNA processing 
alteration and in a gene signature specific for the eye (A) Venn Diagram 
indicating genes differentially expressed in GMR>eIF6 larval eye imaginal discs and 
GMR>eIF6 retinae with respect to control (GMRGAL4/+). (B) The Ecdysone 
Biosynthetic Pathway is shut-down when eIF6 is upregulated. Heat Map 
representing absolute gene expression levels in GMR>eIF6 and GMRGAL4/+ eye 
imaginal disc samples for the subset of gene sets involved in Ecdysone Biosynthesis 
by Gene Ontology analysis. (C) Gene Set Association Analysis (GSAA) indicates a 
significant upregulation of the ribosomal machinery. Representative Enrichment 
Plots indicating a striking upregulation of genes involved in rRNA Processing (NAS: 
2.24; FDR: 6,84E10-4) and Ribosome Biogenesis (NAS: 2.10; FDR: 0,013) in both 
GMR>eIF6 eye imaginal discs and GMR>eIF6 retinae with respect to their control 
(GMRGAL4/+). (D) mRNAs involved in Programmed Cell Death and in Eye 
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Differentiation are upregulated in GMR>eIF6 retinae. Heat Map representing 
absolute gene expression levels in GMR>eIF6 and GMRGAL4/+ retinae samples for 
the subset of gene sets involved in Programmed Cell Death and Eye Differentiation 
by Gene Ontology Analysis.  
Fig 6. Increased eIF6 levels in the developing eye result in reduced free 60S 
and increased translation. (A) iRIA assays showing that eIF6 increased dosage 
reduce the number of free 60S subunits. Values represent the mean ± SEM from two 
replicates. Assays were repeated three times. Student’s t-test was used to calculate 
p-values. (B) In vitro SUnSET assays showing that eIF6 increased gene is 
associated with increased puromycin incorporation. Barplots represent the mean ± 
SEM from three replicates. Assays were repeated three times. Student’s t-test was 
used to calculate p-values. Quantification of SUnSET assay was performed with 
ImageJ software. (C) Representative SUnSET assay performed using 
immunofluorescence experiments, indicating a two-fold increase in general 
translation when eIF6 levels are increased in eye imaginal discs. Scale bar 10 µm. 
(D) Adult wings MS>eIF6 have a completely aberrant phenotype. Scale bar 200 µm. 
(E) In vitro SUnSET assays showing that eIF6 increased gene is associated with 2-
fold puromycin incorporation in wing discs. Barplots represent the mean ± SEM from 
three replicates. Assays were repeated three times. Student’s t-test was used to 
calculate p-values. Quantification of SUnSET assay was performed with ImageJ 
software. 
 
Fig 7. 20HE treatment rescues the rough eye phenotype due to high levels of 
eIF6, unveiling the role of translation in ecdysone biosynthesis regulation. (A-
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C) 20HE treatment partially rescue the rough eye phenotype and the delay in 
apoptosis in 40h APF retinae (A) The barplot represents the average of n>8 
independently collected samples with error bars indicating the SEM. P-values were 
calculated using an unpaired two-tailed Student t-test. The graph shows the 
GMR>eIF6 adult fly eye size with or without treatment with 20HE. As indicated in the 
barplot, the fly eye size is partially rescued when the hormone is added to the fly 
food. (B) Representative stereomicroscope images of GMR>eIF6 eyes treated 
(upper panel) or untreated (lower panel) with 20HE, showing a partial rescue of the 
eye size when 20HE has been added. Scale bar 100 µm (C) Immunofluorescence 
images showing that 20HE treatment (240 µg/mL in standard fly food) rescues the 
apoptotic delay observed in GMR>eIF6 40h APF retinae. Scale bar 50 µm (D-F) 
Real-time PCR analyses of the indicated genes showing an inverse correlation 
between eIF6 and shd mRNA levels. The RNA level of each gene was calculated 
relative to RpL32 expression as a reference gene. The barplot represents the 
average of at least three independent biological replicates with error bars indicating 
the SEM. p-values were calculated using an unpaired two-tailed Student t-test. (D) 
Real-time PCR analyses of the indicated genes in GMRGAL4/+ and GMR>eIF6 eye 
imaginal discs. Upon eIF6 overexpression, GMR>eIF6 eye imaginal discs have less 
abundance of shd mRNA levels compared to GMRGAL4/+ eye imaginal discs. (E-F) 
During development, eIF6 and shd mRNA levels show an inverse correlation by 
comparing embryos with first instar larval RNA extracts (E) or by comparing first and 
third instar larval RNA extracts (F). (G) Ecdysone titers in GMR>eIF6 and 
GMRGAL4/+ eye imaginal discs and 40h APF retinae. 20HE levels decrease in 40h 
APF GMR>eIF6 retinae respect to control retinae. (H-J) The ecdysone biosynthetic 
pathway genes shd and EcR are modulated upon translation modulation in S2 cells. 
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(H) Real time analysis evidences that upon inhibition of translation with rapamycin 
treatment (1 µM, 2 hours) the level of shd and EcR mRNA levels increase, contrary 
to the drop observed upon translation stimulation with insulin (1 µM, 12 hours). The 
RNA level of each gene was calculated relative to RpL32 expression as a reference 
gene. The barplot represents the average of at least three independent biological 
replicates with error bars indicating the SEM. p-values were calculated using an 
upaired two-tailed Student t-test. (J). Representative western blot showing the 
decreased or increased rate of protein synthesis upon rapamycin or insulin treatment 
respectively with SUnSET method (36) 
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HIGHLIGHTS 
• eIF6 high levels result in heightened general translation  
• Ecdysone biosynthesis and general translational rate are inversely correlated  
• Apoptosis is delayed by ecdysone biosynthesis shut-down during development 
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Key Resource Table 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit anti-eIF6 This study N/A 
Rabbit anti-β-actin  Cell Signaling 
Technology 
RRID:AB_330288 
Mouse anti-Puromycin (clone 12D10) Millipore RRID:AB_2566826 
Rat anti-Elav DHSB RRID:AB_528218 
Mouse anti-Cut DSHB RRID:AB_528186 
Mouse anti-Armadillo DSHB RRID:AB_528089 
Mouse anti-Chaoptin DSHB RRID:AB_528161 
Rabbit anti-Dcp-1  Cell Signaling 
Technology 
RRID:AB_2721060 
Sheep anti-mouse IgG-HRP GE Healthcare RRID:AB_772210 
Donkey anti-rabbit IgG-HRP GE Healthcare RRID:AB_772206 
Goat anti-mouse IgG, Alexa Fluor 488 Life Technologies RRID:AB_142924 
Goat anti-rabbit IgG, Alexa Fluor 568 Life Technologies RRID:AB_143157 
Goat anti-rat IgG, Alexa Fluor 647 Life Technologies RRID:AB_141778 
Chemicals, Peptides, and Recombinant Proteins 
Rapamycin Sigma Cat#R8781 
Insulin Sigma Cat#I0516 
Puromycin ThermoFisher 
Scientific 
Cat#A1113803 
Protease Inhibitors Sigma Cat#P8340 
20-HydroxyEcdysone Sigma Cat#H5142 
DAPI Molecular Probes Cat#D3571 
DurcupanTM ACM Sigma Cat#44610-1EA 
Critical Commercial Assays 
BCA Protein Assay Kit Pierce Cat#23227 
In Situ Cell Death Detection Kit TMR 
Red 
Roche Cat#12156792910 
SuperScript III First-Strand Synthesis 
SuperMix for qRT-PCR 
Invitrogen Cat#11752-050 
SuperSignalTM West Pico PLUS 
Chemiluminescent Substrate 
ThermoFisher 
Scientific 
Cat#34577 
mirVanaTM miRNA Isolation Kit Life Technologies Cat#AM1560 
DNA-free™ DNA Removal Kit Life Technologies Cat#AM1906 
Qubit® RNA Assay Kit Life Technologies Cat#Q32852 
TaqMan® Universal PCR Master Mix Life Technologies Cat#4304437 
GoTaq® qPCR Master Mix Promega Cat#A6001 
TruSeq RNA Library Prep Kit v2 Illumina Cat#RS-122-2001 
SBS Kit v3 Illumina Cat#FC-401-3001 
Enzyme Immunoassay Kit Bertin Pharma Cat#A05120.96 
Deposited Data 
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Accession number ID will be provided 
upon acceptance for publication 
ArrayExpress N/A 
Experimental Models: 
Organisms/Strains 
  
D. melanogaster: GMRGAL4/CTG A gift from Manolis 
Fanto (King’s 
College, London) 
N/A 
D. melanogaster: UAS-eIF6 A gift from William J 
Brook (Alberta 
Children’s Hospital, 
Calgary) 
N/A 
D. melanogaster: y[1] w[*]; 
P{w[+mC]=tubP-GAL4}LL7/TM3, Sb[1] 
Ser[1] 
Bloomington 
Drosophila Stock 
center 
BDSC: 5138 
D. melanogaster: P{w[+mC]=spa-
GAL4.J}1, w[*] 
Bloomington 
Drosophila Stock 
center 
BD C: 26656 
D. melanogaster: y[1] w[*]; 
P{w[+m*]=GAL4}54C 
Bloomington 
Drosophila Stock 
center 
BDSC: 27328 
D. melanogaster: w[1118] Bloomington 
Drosophila Stock 
center 
BDSC: 3605 
D. melanogaster: w[1118] 
P{w[+mW.hs]=GawB}Bx[MS1096] 
Bloomington 
Drosophila Stock 
center 
BDSC: 8860 
Experimental Models: Cell Lines 
D. melanogaster: Schneider S2 cells DGRC RRID:CVCL_TZ72 
Oligonucleotides 
Drosophila eIF6 Applied Biosystem CAT#Dm01844498_g1 
Drosophila RPL32 Applied Biosystem CAT#Dm02151827_g1 
Drosophila Shd Metabion  F 5’-
CGGATCGATATGCTAAGCTG
T-3’, R 5’-
CGACGCACTCYCYYGTCG-3’ 
Drosophila RPL32 Metabion F 5’- 
TCTCGCTCTTGTCGTGTCTG
-3’, R 5’- 
CCGATATCCTTCGCGTACTG 
-3’ 
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Software and Algorithms   
R environment for statistical computing 
(version 3.3.1) 
N/A https://www.r-project.org/ 
FastQC (version 0.11.2) Andrews, S. (2014) http://www.bioinformatics.babra
ham.ac.uk/projects/fastqc 
Trimmomatic (version 0.32) Bolger, A. M. et al. 
(2014) 
http://www.usadellab.org/cms/?
page=trimmomatic 
STAR software (version 2.4.1c) Dobin, A. et al. 
(2013) 
https://github.com/alexdobin/S
TAR 
HTSeq-count (version 0.6.1) Anders, S. et al. 
(2015) 
https://pypi.org/project/HTSeq/ 
DESeq2 (version DESeq2_1.12.4) Love, M.I. et al. 
(2014) 
https://github.com/mikelove/DE
Seq2 
topGO (version topGO_2.24.0) Alexa, A. et al. 
(2016) 
https://bioconductor.org/packag
es/release/bioc/html/topGO.ht
ml 
GSAA (version 2.0) Xiong, Q. et al. 
(2014) 
http://gsaa.unc.edu/ 
Volocity (version 6.3) Quorum 
Technologies 
http://quorumtechnologies.com/
index.php/2014-06-19-13-10-
00/2014-06-19-13-14-
30/image-analysis/2-
uncategorised/110-volocity-
downloads 
Microsoft Excel  Microsoft https://www.microsoft.com/ 
ImageJ ImageJ https://imagej.nih.gov/ij/ 
GraphPad 7 Prism https://www.graphpad.com/scie
ntific-software/prism/ 
 
Contact for Reagent and Resource Sharing 
Further information and requests for reagents may be directed to, and will be fulfilled by the 
corresponding authors Piera Calamita (calamita@ingm.org) and Stefano Biffo (biffo@ingm.org). 
